SUPREME COURT ALTERS THE STANDARD OF REVIEW FOR PATENT CLAIM CONSTRUCTION: 美最高法院改变对专利诉求范围解释的复审标准
In Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., (574 U.S. ___(2105) (Slip Opinion Jan. 20, 2015), the Supreme Court of the United States held that the review of Markman claim construction decisions is now considered a mixed question of fact and law. Any factual determinations based on extrinsic evidence will be reviewed for clear error. The …